Many MS patients suffer from visual loss, optic neuritis and RGC degeneration, however any association between the role of Shp2 in myelination and its possible impact on optic nerve has not been investigated (Gundogan et al., 2011; London et al., 2012). Here, PTPN11 is linked to myeloid sarcoma.